LIXIL Corporation (TJS) - Net Assets
Based on the latest financial reports, LIXIL Corporation (TJS) has net assets worth €639.39 Billion EUR as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.87 Trillion) and total liabilities (€1.23 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €639.39 Billion |
| % of Total Assets | 34.24% |
| Annual Growth Rate | 0.27% |
| 5-Year Change | 11.77% |
| 10-Year Change | 15.4% |
| Growth Volatility | 8.42 |
LIXIL Corporation - Net Assets Trend (2014–2025)
This chart illustrates how LIXIL Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for LIXIL Corporation (2014–2025)
The table below shows the annual net assets of LIXIL Corporation from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | €620.07 Billion | -3.77% |
| 2024-03-31 | €644.34 Billion | +2.65% |
| 2023-03-31 | €627.72 Billion | +2.07% |
| 2022-03-31 | €614.97 Billion | +10.85% |
| 2021-03-31 | €554.77 Billion | +3.67% |
| 2020-03-31 | €535.14 Billion | -5.65% |
| 2019-03-31 | €567.17 Billion | -12.69% |
| 2018-03-31 | €649.57 Billion | +16.11% |
| 2017-03-31 | €559.43 Billion | +4.12% |
| 2016-03-31 | €537.31 Billion | -12.44% |
| 2015-03-31 | €613.65 Billion | +1.97% |
| 2014-03-31 | €601.79 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to LIXIL Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 21.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €206.64 Billion | 33.44% |
| Other Components | €411.25 Billion | 66.56% |
| Total Equity | €617.89 Billion | 100.00% |
LIXIL Corporation Competitors by Market Cap
The table below lists competitors of LIXIL Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
RP Optical Lab Ltd
TA:RPOL
|
$2.84 Billion |
|
Spyre Therapeutics Inc.
NASDAQ:SYRE
|
$2.84 Billion |
|
Guangxi Liugong Machinery Co Ltd
SHE:000528
|
$2.84 Billion |
|
Northeast Securities Co Ltd
SHE:000686
|
$2.84 Billion |
|
Altarea SCA
PA:ALTA
|
$2.84 Billion |
|
Haemonetics Corporation
NYSE:HAE
|
$2.84 Billion |
|
Corporativo Fragua S.A.B. de C.V
MX:FRAGUAB
|
$2.84 Billion |
|
Motherson Sumi Wiring India Limited
NSE:MSUMI
|
$2.83 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LIXIL Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 642,511,000,000 to 617,886,000,000, a change of -24,625,000,000 (-3.8%).
- Net income of 2,001,000,000 contributed positively to equity growth.
- Dividend payments of 25,849,000,000 reduced retained earnings.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €2.00 Billion | +0.32% |
| Dividends Paid | €25.85 Billion | -4.18% |
| Other Changes | €-777.00 Million | -0.13% |
| Total Change | €- | -3.83% |
Book Value vs Market Value Analysis
This analysis compares LIXIL Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-03-31 | €1902.18 | €8.45 | x |
| 2018-03-31 | €2128.77 | €8.45 | x |
| 2019-03-31 | €1839.59 | €8.45 | x |
| 2020-03-31 | €1730.99 | €8.45 | x |
| 2021-03-31 | €1902.89 | €8.45 | x |
| 2022-03-31 | €2106.30 | €8.45 | x |
| 2023-03-31 | €2178.77 | €8.45 | x |
| 2024-03-31 | €2237.53 | €8.45 | x |
| 2025-03-31 | €2150.86 | €8.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LIXIL Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.32%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.13%
- • Asset Turnover: 0.82x
- • Equity Multiplier: 2.96x
- Recent ROE (0.32%) is below the historical average (2.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 3.52% | 1.29% | 0.91x | 3.00x | €-38.65 Billion |
| 2015 | 3.63% | 1.32% | 0.89x | 3.09x | €-38.59 Billion |
| 2016 | -4.88% | -1.35% | 0.89x | 4.06x | €-78.09 Billion |
| 2017 | 7.77% | 2.38% | 0.87x | 3.73x | €-12.22 Billion |
| 2018 | 8.85% | 3.28% | 0.79x | 3.42x | €-7.11 Billion |
| 2019 | -9.78% | -2.85% | 0.89x | 3.86x | €-105.56 Billion |
| 2020 | 2.49% | 0.74% | 0.81x | 4.17x | €-37.70 Billion |
| 2021 | 5.98% | 2.40% | 0.79x | 3.15x | €-22.18 Billion |
| 2022 | 7.94% | 3.40% | 0.80x | 2.91x | €-12.64 Billion |
| 2023 | 2.56% | 1.07% | 0.81x | 2.96x | €-46.55 Billion |
| 2024 | -2.16% | -0.94% | 0.79x | 2.94x | €-78.16 Billion |
| 2025 | 0.32% | 0.13% | 0.82x | 2.96x | €-59.79 Billion |
Industry Comparison
This section compares LIXIL Corporation's net assets metrics with peer companies in the Building Products & Equipment industry.
Industry Context
- Industry: Building Products & Equipment
- Average net assets among peers: $12,072,286,400
- Average return on equity (ROE) among peers: -8.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LIXIL Corporation (TJS) | €639.39 Billion | 3.52% | 1.92x | $2.84 Billion |
| FM MATTSSON MORA GR.B (1FS0) | $1.07 Billion | 13.53% | 0.71x | $354.21 Million |
| CONCEJO AB (PUBL) B SK 5 (3W1) | $735.10 Million | -6.31% | 0.43x | $48.38 Million |
| ECOCLIME GRP AB B (5V0) | $144.72 Million | -37.25% | 0.09x | $9.43K |
| BUNKA SHUTTER (7VK) | $113.45 Billion | 11.60% | 0.81x | $736.89 Million |
| Zenergy AB (publ) (8T40) | $13.61 Million | -99.07% | 1.63x | $172.99K |
| AAON INC. DL-004 (AAO) | $560.71 Million | 17.90% | 0.45x | $6.06 Billion |
| CHINA GLASS HLDGS (C8G1) | $2.17 Billion | -3.91% | 2.32x | $372.16 Million |
| Centrotec SE (CEV) | $346.19 Million | 10.12% | 1.63x | $776.91 Million |
| ARISTON HOLD.N.V. EO-01 (E0E) | $1.43 Billion | 0.18% | 1.50x | $566.92 Million |
| Borgestad ASA (H460) | $809.03 Million | 5.59% | 0.81x | $54.93 Million |
About LIXIL Corporation
LIXIL Corporation, through its subsidiaries, operates water technology and housing technology business in Japan and internationally. The company offers fixtures and vanities, which includes ceramic toilets, bidets, urinals, and basins, and vanities; bathing products, such as bath tubs, showers enclosures, whirlpool, and wellness solutions; and bathroom fittings, including single and two lever fau… Read more